PUFA and intrahepatic cholestasis of pregnancy: a two-sample Mendelian randomisation analysis.

This study aimed to explore the potential causal association between PUFA and the risk of intrahepatic cholestasis of pregnancy (ICP) using Mendelian randomisation (MR) analysis. A two-sample MR analysis was conducted utilising large-scale European-based genome-wide association studies summary databases. The primary MR analysis was carried out using the inverse variance-weighted (IVW) method, complemented by other methods such as MR-egger, weighted-median and weighted mode. Sensitivity analysis was also performed to validate the robustness of the findings. Results indicated a 31 % reduced risk of ICP for every 1 standard deviation (sd) increase in -3 fatty acids levels (OR = 0·69, 95 % CI: 0·54, 0·89, = 0·004) and in the ratio of -3 fatty acids to total fatty acids (OR = 0·69, 95 % CI: 0·53, 0·91, = 0·008). Conversely, there was a 51 % increased risk of ICP for every 1 sd increase in the ratio of -6 fatty acids to -3 fatty acids (OR = 1·51, 95 % CI: 1·20, 1·91, < 0·001) and a 138 % increased risk for every 1 sd increase in the ratio of linoleic fatty acids to total fatty acids (OR = 2·38, 95 % CI: 1·55, 3·66, < 0·001). The findings suggest that -3 fatty acids may have a protective effect against the risk of ICP, while -6 fatty acids and linoleic fatty acids could be potential risk factors for ICP. The supplementation of -3 fatty acids, as opposed to -6 fatty acids, could be a promising strategy for the prevention and management of ICP.